Biolife solutions reports first quarter 2025 financial results

Cell processing revenue of $21.6 million, up 33% over q1 2024 gaap gross margin of 63%  and non-gaap adjusted gross margin of 66% gaap net loss of $0.4 million and non-gaap adjusted ebitda of $5.7 million or 24% of revenue conference call begins at 4:30 p.m. eastern time today bothell, wash.
BLFS Ratings Summary
BLFS Quant Ranking